AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) will present new data from studies evaluating two of its internally developed, next-generation, investigational oncology therapies that it has global rights ...

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

The study’s small size limits interpretation, but it remains the largest real-world data available, experts said.

The Mediterranean diet shows promise in managing both systemic and organ-specific autoimmune diseases, including rheumatoid arthritis and autoimmune thyroiditis. Its anti-inflammatory and ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

CEL-SCI Corporation announced that it met with the Saudi Food and Drug Authority (SFDA) to discuss the development of ...

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) announced that an abstract was accepted for presentation at the Plenary Session at the American Society of Clinical Oncology (ASCO) ...

A new study shows that combining heavy alcohol use with burn trauma causes severe disruptions in the gut microbiome, leading ...

2025年4月17日，赛诺菲与专注AI驱动药物开发的Earendil Labs达成重磅合作，双方围绕TL1A（Tumor necrosis factor-like cytokine 1A，肿瘤坏死因子样配体1A）靶点达成两项双抗授权交易。

The US FDA has cleared the IND application of Aclaris to commence the placebo-controlled Phase Ia/Ib study of the ATI-052 ...